Pharmacokinetics and distribution over the blood brain barrier of two acyclic guanosine analogs in rats, studied by microdialysis
Open Access
- 1 February 1992
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (2) , 339-342
- https://doi.org/10.1128/aac.36.2.339
Abstract
The free extracellular concentrations of acyclovir and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) in the blood and in brain tissue of rats were measured in microdialysis samples by high-pressure liquid chromatography with UV detection. The half-life of acyclovir in blood was 2 h, while that of H2G was 28 min. The concentration attained in the brain compared with the concentration in blood was slightly lower for H2G than for acyclovir. The results show that the pharmacokinetic profiles of acyclic nucleosides may vary as a consequence of the structure of the acyclic chain corresponding to the sugar moiety.Keywords
This publication has 6 references indexed in Scilit:
- Drug distribution studies with microdialysis II. Caffeine and theophylline in blood, brain and other tissues in ratsLife Sciences, 1991
- A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysisJournal of Pharmacological Methods, 1991
- Theophylline concentration in the extracellular space of the rat brain: measurement by microdialysis and relation to behaviourEuropean Journal of Pharmacology, 1990
- Azole antifungal agents: emphasis on new triazolesAntimicrobial Agents and Chemotherapy, 1988
- Clinical Pharmacokinetics of AcyclovirClinical Pharmacokinetics, 1983
- The disposition of acyclovir in different species.1981